ScholarIQanswers from OpenAlex
Pharmacovigilance and Adverse Drug Reactions
TopicLeading institutions, researchers & key papers
Pharmacovigilance and Adverse Drug Reactions is a topic indexed in ScholarIQ from OpenAlex.
What is known about Pharmacovigilance and Adverse Drug Reactions?
ScholarIQrecord summary
This cluster of papers focuses on the study, detection, monitoring, and reporting of adverse drug reactions (ADRs) through pharmacovigilance. It covers various aspects such as signal detection, drug safety surveillance, data mining techniques, patient reporting, regulatory actions, causality assessment, and the impact of ADRs on hospital admissions.
How many works does Pharmacovigilance and Adverse Drug Reactions have?
ScholarIQindexed works
Pharmacovigilance and Adverse Drug Reactions has 138 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Pharmacovigilance and Adverse Drug Reactions?
ScholarIQopenalex
The OpenAlex for Pharmacovigilance and Adverse Drug Reactions is on the source record.
What are the most-cited papers on Pharmacovigilance and Adverse Drug Reactions?
ScholarIQmost cited works
The Danish National Prescription Registry
Helle Wallach‐Kildemoes, Henrik Toft Sørensen, Jesper Hallas
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
Eugène van Puijenbroek, Andrew Bate, Hubert G.M. Leufkens, Marie Lindquist, Roland Orre, Toine C. G. Egberts
The reporting odds ratio and its advantages over the proportional reporting ratio
Kenneth J. Rothman, Stephan Lanes, Susan T. Sacks
Adverse drug events in hospitalized patients
Patricia M. L. A. van den Bemt, Toine C. G. Egberts, A.W. Lenderink, J.M. Verzijl, Katherine Simons, W.S.C.J.M. van der Pol, Hubert G.M. Leufkens
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury, Matthieu Mahévas, Khalil El Karoui, Lydia Roy, Anissa Zarour, Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, P. Wolkenstein, Philippe Grimbert, É. Sbidian
Where is Pharmacovigilance and Adverse Drug Reactions research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Pharmacovigilance and Adverse Drug Reactions is open access?
ScholarIQopen access share
60%OPEN ACCESS